Abstract
Objective: 1) Determine the diagnostic yield of a shared genetic screening algorithm in adult and pediatric populations with sensorineural hearing loss (SNHL). 2) Recommend effective testing strategies to evaluate for genetic causes of deafness in patients presenting with idiopathic sensorineural hearing loss.
Method: A total of 221 adult and 163 pediatric patients with non-syndromic sensorineural hearing impairment were recruited from otology clinics between 2001 and 2011. Peripheral blood samples were screened for mutations in GJB2 and GJB6 and mitochondrial DNA mutations 1555A>G, 7444G>A, and 3243A>G. Audiometric data and family history were also collected.
Results: GJB2/GJB6 related deafness was diagnosed in 23 out of 163 pediatric patients (14%) compared with only 3 out of 221 adults (1%). All 3 adults had a family history of hearing loss, and 2 patients noted deafness onset at birth. Nineteen GJB2 mutations were identified with 35delG, the most common mutation. The 35delG homozygous state was the most common pathogenic genotype (54%). Mitochondrial DNA (mtDNA) mutations were found in 6 adult probands (3%). No mtDNA mutations were found in pediatric patients.
Conclusion: Testing for common GJB2/GJB6 mutations in pediatric patients has considerable value in establishing an etiologic diagnosis for SNHL. Similar testing in adults is of very low yield except perhaps in cases of early onset HL or strong family history. Mitochondrial DNA testing should be considered in adults with idiopathic SNHL.
Get full access to this article
View all access options for this article.